Agios Pharmaceuticals Inc. buy Bank of America Co.
Start price
20.11.25
/
50%
€20.00
Target price
20.11.26
€27.77
Performance (%)
20.00%
Price
05.03.26
€24.00
Summary
This prediction is currently active. The prediction currently has a performance of 20.00%. This prediction currently runs until 20.11.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | -6.977% | -6.977% |
| iShares Core DAX® | -5.868% | -2.496% |
| iShares Nasdaq 100 | 1.660% | 3.513% |
| iShares Nikkei 225® | -6.126% | 2.136% |
| iShares S&P 500 | 0.504% | 2.045% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at Bank of America Corporation from $54.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.80
24.12.25
24.12.25
€28.80
24.12.26
24.12.26
0.84%
05.03.26
05.03.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€33.80
22.07.25
22.07.25
€43.63
22.07.26
22.07.26
-30.18%
05.03.26
05.03.26